| - GRCh37:
- Chr22:30038230
- GRCh38:
- Chr22:29642241
| NF2 | P135S, P52S, P58S, P93S, P94S, P97S | Neurofibromatosis, type 2 | Uncertain significance (Dec 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30051572
- GRCh38:
- Chr22:29655583
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30074175-30090791
| NF2 | | Neurofibromatosis, type 2 | Uncertain significance (Nov 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30050636-30051675
| NF2 | | Neurofibromatosis, type 2 | Pathogenic (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30032730-30064445
| NF2 | | Neurofibromatosis, type 2 | Pathogenic (Jul 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30077418-30090791
| NF2 | | Neurofibromatosis, type 2 | Pathogenic (Oct 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30074175-30077600
| NF2 | | Neurofibromatosis, type 2 | Likely pathogenic (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30070815-30077600
| NF2 | | Neurofibromatosis, type 2 | Pathogenic (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30077429
- GRCh38:
- Chr22:29681440
| NF2 | V348M, V440M, V443M, V449M, V481M, V484M, V485M, V488M, V526M | Neurofibromatosis, type 2 | Uncertain significance (Jul 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30077604
- GRCh38:
- Chr22:29681615
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30077461
- GRCh38:
- Chr22:29681472
| NF2 | Q358H, Q450H, Q453H, Q459H, Q491H, Q494H, Q495H, Q498H, Q536H | Neurofibromatosis, type 2 | Uncertain significance (Jan 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30032777
- GRCh38:
- Chr22:29636788
| NF2 | C13F, C51F | Neurofibromatosis, type 2 | Uncertain significance (May 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30069251
- GRCh38:
- Chr22:29673262
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Dec 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30069480
- GRCh38:
- Chr22:29673491
| NF2 | | Neurofibromatosis, type 2 | Uncertain significance (Aug 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30050713
- GRCh38:
- Chr22:29654724
| NF2 | R89M, R134M, R172M, R130M, R131M, R95M | Neurofibromatosis, type 2, Inborn genetic diseases | Uncertain significance (Jun 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:30067904
- GRCh38:
- Chr22:29671915
| NF2 | M280I, M321I, M325I, M318I, M277I, M286I, M322I, M185I, M363I | Neurofibromatosis, type 2 | Uncertain significance (May 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30032722
- GRCh38:
- Chr22:29636733
| NF2 | | Neurofibromatosis, type 2 | Likely benign (May 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30070883
- GRCh38:
- Chr22:29674894
| NF2 | R384G, R429G, R467G, R390G, R422G, R289G, R381G, R426G, R425G | Neurofibromatosis, type 2 | Uncertain significance (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30032842
- GRCh38:
- Chr22:29636853
| NF2 | A73T, A35T | Neurofibromatosis, type 2 | Uncertain significance (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30051682
- GRCh38:
- Chr22:29655693
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Aug 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30035215
- GRCh38:
- Chr22:29639226
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30067813
- GRCh38:
- Chr22:29671824
| NF2 | | Neurofibromatosis, type 2 | Likely pathogenic (Apr 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30069249
- GRCh38:
- Chr22:29673260
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30000074
- GRCh38:
- Chr22:29604085
| NF2 | M29I | Neurofibromatosis, type 2 | Uncertain significance (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30050666
- GRCh38:
- Chr22:29654677
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30032773
- GRCh38:
- Chr22:29636784
| NF2 | V12M, V50M | Neurofibromatosis, type 2 | Uncertain significance (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30074293
- GRCh38:
- Chr22:29678304
| NF2 | M341V, M436V, M442V, M478V, M433V, M519V, M474V, M477V, M481V | Neurofibromatosis, type 2, Hereditary cancer-predisposing syndrome | Uncertain significance (Dec 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:30077462
- GRCh38:
- Chr22:29681473
| NF2 | E359K, E454K, E499K, E451K, E495K, E460K, E492K, E496K, E537K | Neurofibromatosis, type 2 | Uncertain significance (Feb 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30032878
- GRCh38:
- Chr22:29636889
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Jun 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30035065
- GRCh38:
- Chr22:29639076
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Jul 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30032754
- GRCh38:
- Chr22:29636765
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30069265
- GRCh38:
- Chr22:29673276
| NF2 | S199C, S300C, S335C, S336C, S377C, S291C, S294C, S332C, S339C | Neurofibromatosis, type 2 | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30069480
- GRCh38:
- Chr22:29673491
| NF2 | | Neurofibromatosis, type 2 | Uncertain significance (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30060965
- GRCh38:
- Chr22:29664976
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30077542
- GRCh38:
- Chr22:29681553
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30069391
- GRCh38:
- Chr22:29673402
| NF2 | T378R, T241R, T333R, T336R, T419R, T342R, T374R, T377R, T381R | Neurofibromatosis, type 2 | Uncertain significance (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30035062
- GRCh38:
- Chr22:29639073
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Oct 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30069459
- GRCh38:
- Chr22:29673470
| NF2 | E264K, E356K, E365K, E359K, E400K, E442K, E397K, E401K, E404K | Neurofibromatosis, type 2 | Uncertain significance (Aug 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30064333
- GRCh38:
- Chr22:29668344
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Feb 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30035079
- GRCh38:
- Chr22:29639090
| NF2 | V81I, V43I, V39I, V4I | Neurofibromatosis, type 2 | Uncertain significance (Apr 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30035197
- GRCh38:
- Chr22:29639208
| NF2 | L82S, L43S, L120S, L78S | Neurofibromatosis, type 2 | Uncertain significance (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30035129
- GRCh38:
- Chr22:29639140
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30000120
- GRCh38:
- Chr22:29604131
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Oct 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30035123
- GRCh38:
- Chr22:29639134
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Jul 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30067832
- GRCh38:
- Chr22:29671843
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Mar 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30050667
- GRCh38:
- Chr22:29654678
| NF2 | V116L, V74L, V80L, V119L, V157L, V115L | Neurofibromatosis, type 2 | Uncertain significance (May 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30077478
- GRCh38:
- Chr22:29681489
| NF2 | L364H, L456H, L500H, L459H, L465H, L501H, L542H, L497H, L504H | Neurofibromatosis, type 2 | Uncertain significance (May 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30074301-30074304
- GRCh38:
- Chr22:29678312-29678315
| NF2 | E439fs, E481fs, E480fs, E522fs | Neurofibromatosis, type 2 | Pathogenic (Mar 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30067899
- GRCh38:
- Chr22:29671910
| NF2 | Q184*, Q276*, Q285*, Q321*, Q279*, Q317*, Q320*, Q362*, Q324* | Neurofibromatosis, type 2 | Pathogenic (Mar 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30057323
- GRCh38:
- Chr22:29661334
| NF2 | K186*, K227*, K228*, K192*, K269*, K91*, K231* | Neurofibromatosis, type 2 | Pathogenic (May 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30057193
- GRCh38:
- Chr22:29661204
| NF2 | | Neurofibromatosis, type 2 | Pathogenic (May 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30054258
- GRCh38:
- Chr22:29658269
| NF2 | | Neurofibromatosis, type 2 | Uncertain significance (Sep 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30035107
- GRCh38:
- Chr22:29639118
| NF2 | E48fs, E90fs | Neurofibromatosis, type 2 | Pathogenic (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30077529
- GRCh38:
- Chr22:29681540
| NF2 | D559fs, D518fs, D476fs, D517fs | Neurofibromatosis, type 2 | Uncertain significance (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30032784
- GRCh38:
- Chr22:29636795
| NF2 | | Neurofibromatosis, type 2 | Likely benign (May 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30038278
- GRCh38:
- Chr22:29642289
| NF2 | | Neurofibromatosis, type 2 | Uncertain significance (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30070906
- GRCh38:
- Chr22:29674917
| NF2 | E388D, E432D, E296D, E397D, E436D, E391D, E429D, E433D, E474D | Neurofibromatosis, type 2 | Uncertain significance (Apr 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30064450
- GRCh38:
- Chr22:29668461
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Apr 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30077486
- GRCh38:
- Chr22:29681497
| NF2 | E462K, E545K, E459K, E500K, E507K, E503K, E367K, E468K, E504K | Neurofibromatosis, type 2 | Uncertain significance (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30051658-30051981
- GRCh38:
- Chr22:29655669-29655992
| NF2 | | Neurofibromatosis, type 2 | Likely pathogenic (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30035212
- GRCh38:
- Chr22:29639223
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Mar 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30069306
- GRCh38:
- Chr22:29673317
| NF2 | T213S, T391S, T346S, T353S, T305S, T308S, T314S, T349S, T350S | Neurofibromatosis, type 2 | Uncertain significance (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30074245
- GRCh38:
- Chr22:29678256
| NF2 | D417N, D420N, D503N, D462N, D325N, D458N, D426N, D461N, D465N | Neurofibromatosis, type 2 | Uncertain significance (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30000105-30000106
- GRCh38:
- Chr22:29604116-29604117
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Mar 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30057264
- GRCh38:
- Chr22:29661275
| NF2 | R172K, R249K, R166K, R211K, R207K, R208K, R71K | Neurofibromatosis, type 2 | Uncertain significance (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30070889
- GRCh38:
- Chr22:29674900
| NF2 | K291Q, K383Q, K428Q, K427Q, K469Q, K386Q, K392Q, K424Q, K431Q | Neurofibromatosis, type 2 | Uncertain significance (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30035079-30035087
- GRCh38:
- Chr22:29639090-29639098
| NF2 | V39fs, V81fs | Neurofibromatosis, type 2 | Pathogenic (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30035166
- GRCh38:
- Chr22:29639177
| NF2 | V33I, V68I, V72I, V110I | Neurofibromatosis, type 2 | Uncertain significance (Feb 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30069411
- GRCh38:
- Chr22:29673422
| NF2 | M340V, M349V, M384V, M385V, M343V, M381V, M388V, M426V, M248V | Neurofibromatosis, type 2 | Uncertain significance (May 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30077483
- GRCh38:
- Chr22:29681494
| NF2 | T458P, T366P, T461P, T502P, T506P, T467P, T499P, T503P, T544P | Neurofibromatosis, type 2 | Uncertain significance (Feb 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30067895-30067896
- GRCh38:
- Chr22:29671906-29671907
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Feb 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30074242
- GRCh38:
- Chr22:29678253
| NF2 | G419S, G425S, G457S, G460S, G324S, G416S, G502S, G461S, G464S | Neurofibromatosis, type 2 | Uncertain significance (Jan 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30069338
- GRCh38:
- Chr22:29673349
| NF2 | K223N, K363N, K359N, K360N, K401N, K315N, K318N, K324N, K356N | Neurofibromatosis, type 2, Hereditary cancer-predisposing syndrome | Uncertain significance (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:30090727
- GRCh38:
- Chr22:29694738
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Jan 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30077418
- GRCh38:
- Chr22:29681429
| NF2 | | Neurofibromatosis, type 2 | Likely benign (May 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30070950
- GRCh38:
- Chr22:29674961
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30074242
- GRCh38:
- Chr22:29678253
| NF2 | G419C, G457C, G464C, G502C, G416C, G461C, G324C, G425C, G460C | Neurofibromatosis, type 2 | Uncertain significance (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30077543
- GRCh38:
- Chr22:29681554
| NF2 | E478K, E487K, E564K, E481K, E519K, E522K, E386K, E523K, E526K | Neurofibromatosis, type 2 | Uncertain significance (Sep 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30074328
- GRCh38:
- Chr22:29678339
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Oct 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30032720-30032721
- GRCh38:
- Chr22:29636731-29636732
| NF2 | | Neurofibromatosis, type 2 | Uncertain significance (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30069430
- GRCh38:
- Chr22:29673441
| NF2 | E355G, E387G, E394G, E254G, E432G, E346G, E349G, E390G, E391G | Neurofibromatosis, type 2 | Uncertain significance (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30051654
- GRCh38:
- Chr22:29655665
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30051675
- GRCh38:
- Chr22:29655686
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Sep 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30069488
- GRCh38:
- Chr22:29673499
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Oct 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30035162
- GRCh38:
- Chr22:29639173
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Oct 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30051571
- GRCh38:
- Chr22:29655582
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Dec 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30057342
- GRCh38:
- Chr22:29661353
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Sep 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30000048
- GRCh38:
- Chr22:29604059
| NF2 | T21A | Neurofibromatosis, type 2 | Uncertain significance (Aug 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30069337
- GRCh38:
- Chr22:29673348
| NF2 | K223R, K318R, K356R, K359R, K401R, K315R, K324R, K363R, K360R | Neurofibromatosis, type 2 | Uncertain significance (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30000112
- GRCh38:
- Chr22:29604123
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Oct 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30069363-30069364
- GRCh38:
- Chr22:29673374-29673375
| NF2 | R328fs, R369fs, R370fs, R411fs | Neurofibromatosis, type 2 | Pathogenic (Dec 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30050709
- GRCh38:
- Chr22:29654720
| NF2 | K129E, K171E, K130E, K94E, K133E, K88E | Neurofibromatosis, type 2 | Uncertain significance (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30070947
- GRCh38:
- Chr22:29674958
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Jul 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30077411
- GRCh38:
- Chr22:29681422
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Feb 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30067858
- GRCh38:
- Chr22:29671869
| NF2 | E262V, E271V, E170V, E306V, E307V, E310V, E348V, E265V, E303V | Neurofibromatosis, type 2 | Uncertain significance (Dec 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30074165
- GRCh38:
- Chr22:29678176
| NF2 | | Neurofibromatosis, type 2 | Likely benign (Oct 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30000036
- GRCh38:
- Chr22:29604047
| NF2 | K17E | Neurofibromatosis, type 2 | Uncertain significance (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30070852
- GRCh38:
- Chr22:29674863
| NF2 | | Neurofibromatosis, type 2, Hereditary cancer-predisposing syndrome | Likely benign (Mar 12, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:30090756-30090770
- GRCh38:
- Chr22:29694767-29694781
| NF2 | | Neurofibromatosis, type 2 | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:30067903
- GRCh38:
- Chr22:29671914
| NF2 | M185T, M277T, M280T, M318T, M325T, M321T, M286T, M322T, M363T | Neurofibromatosis, type 2 | Uncertain significance (Dec 22, 2021) | criteria provided, single submitter |